Robotic gait rehabilitation for people with Parkinson's disease
Robotic Gait Rehabilitation in Parkinson's Disease
NA · Indiana University · NCT05218187
This study is testing if a robotic device can help people with Parkinson's disease walk better and improve their quality of life compared to regular physical therapy.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Indiana University (other) |
| Locations | 1 site (Indianapolis, Indiana) |
| Trial ID | NCT05218187 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of the G-EO System, a robotic gait rehabilitation device, to improve mobility and quality of life in patients with Parkinson's disease who experience gait disorders. It aims to establish the safety and feasibility of this electromechanically-assisted gait training through a single-blinded, randomized trial. Participants will receive either robotic-assisted training or conventional physical therapy, with outcomes measured in terms of mobility, function, and overall quality of life. The study seeks to provide a more efficient and effective rehabilitation approach compared to traditional methods.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with a confirmed diagnosis of Parkinson's disease at Hoehn and Yahr stages 1 to 3 who require functional rehabilitation.
Not a fit: Patients with severe dyskinesia, unstable medication regimens, or significant co-morbidities affecting walking may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance mobility and quality of life for patients with Parkinson's disease.
How similar studies have performed: Preliminary evidence from small studies suggests potential benefits of robotic-assisted gait training, indicating this approach may be promising but is still relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18years * Confirmed diagnosis of Parkinson's Disease * Hoehn and Yahr stage 1 to 3 * Stable course of disease-modifying therapy over the past 3 months * Mini Mental State Examination \> 24 * Physician approval for exercise * Stable deep brain stimulation setting for the past year * Demonstrate a need for functional rehabilitation Exclusion Criteria: * • Severe dyskinesia or severe on-off phenomenon * Unstable medication regiment * Any co-morbidity that will interfere with walking * Conventional physical therapy or G-EO training within the past 6 months * Height \<1m or \>2m * Body weight \>150 kg * Contraindications to G-EO gait training (e.g., bone instability)
Where this trial is running
Indianapolis, Indiana
- IU Health Neurorehabilitation and Robotics — Indianapolis, Indiana, United States (RECRUITING)
Study contacts
- Study coordinator: Peter Altenburger, PhD
- Email: paltenbu@iu.edu
- Phone: 3172780703
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Parkinson Disease, Gait Disorder, Sensorimotor, End-Effector Gait Training, Robot-Assisted Gait Training, Mobility, Function, Quality of Life